Live, recombinant viruses are at present under investigation for immunisation against influenza, since these vaccines may be more acceptable to the public and have been reported to produce a more solid immunity than inactivated virus vaccines (Beare et al., 1968) . A number of candidate vaccine strains have been tested in normal persons with few side effects (Beare et al., 1975; Morris et al., 1975) . Influenza infection is particularly severe and has a high mortality in patients with chronic bronchitis and emphysema. It was thought necessary, therefore, that the effects of influenza viruses should be tested independently in these patients, since these subjects may produce reactions to virus infection which were not detectable in normal volunteers. volunteers and two control subjects showed a substantial fall of the FEVi.o after day 0. Tables 3 and 4 describe the respiratory symptoms which followed immunisation of the test and control groups. Only one of the infected volunteers had distinct symptoms 2-3 days post-infection, but five complained of severe reactions 7 or 14 days after virus inoculation; two volunteers (Nos 5 and 8) continued to have severe symptoms 21 days after infection and had to be admitted to hospital. Of the control subjects (Table 4) , two had definite symptoms 2-3 days post-infection, but in both cases these symptoms had disappeared by day 7. Two other patients developed severe respiratory symptoms during the observation period. Table 5 shows the comparison of the maximum grades of reaction in the two groups of patients. Reaction rates were significantly greater for virusinfected volunteers than for control subjects. Nine of 10 test subjects showed a grade 2 or greater reaction at some time during the observation period. Professor Sir Charles Stuart-Harris gave much appreciated help and criticism.
Patients and methods

Nineteen
The work was part of the studies undertaken by members of the MRC Committee on influenza and other respiratory virus vaccines-ad hoc group on pulmonary function tests. 
